Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $123,907 | 47 | 82.6% |
| Unspecified | $19,659 | 3 | 13.1% |
| Travel and Lodging | $5,710 | 9 | 3.8% |
| Food and Beverage | $804.26 | 10 | 0.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $50,034 | 9 | $0 (2019) |
| Amgen Inc. | $24,280 | 14 | $0 (2023) |
| GlaxoSmithKline, LLC. | $21,327 | 10 | $0 (2022) |
| Novartis Pharma AG | $14,709 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $10,550 | 8 | $0 (2022) |
| Genentech, Inc. | $6,172 | 4 | $0 (2019) |
| Eli Lilly and Company | $6,019 | 6 | $0 (2022) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $3,599 | 1 | $0 (2023) |
| Janssen Research & Development, LLC | $3,125 | 2 | $0 (2020) |
| UCB GmBH | $2,456 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $26,309 | 7 | Novartis Pharma AG ($14,709) |
| 2022 | $13,718 | 10 | Amgen Inc. ($11,600) |
| 2021 | $8,610 | 5 | Amgen Inc. ($5,800) |
| 2020 | $7,440 | 5 | Janssen Research & Development, LLC ($3,100) |
| 2019 | $41,307 | 17 | Celgene Corporation ($25,000) |
| 2018 | $13,925 | 5 | Celgene Corporation ($6,250) |
| 2017 | $38,772 | 20 | Celgene Corporation ($18,784) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2023 | Novartis Pharma AG | COSENTYX (Biological) | — | Cash or cash equivalent | $14,600.00 | Research |
| Study: Rheumatology Pipeline Studies • Category: IMMUNOLOGY | ||||||
| 12/12/2023 | Novartis Pharma AG | COSENTYX (Biological) | — | Cash or cash equivalent | $109.23 | Research |
| Study: Rheumatology Pipeline Studies • Category: IMMUNOLOGY | ||||||
| 09/22/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | In-kind items and services | $3,599.31 | General |
| 05/02/2023 | IDORSIA PHARMACEUTICALS US INC | CENERIMOD | Consulting Fee | Cash or cash equivalent | $1,620.00 | General |
| 03/27/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 03/08/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| 01/17/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 12/21/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,160.00 | General |
| 11/11/2022 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $45.94 | General |
| 09/22/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 08/25/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 05/26/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $576.76 | General |
| Category: IMMUNOLOGY | ||||||
| 05/24/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 05/20/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 05/12/2022 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $1,495.00 | General |
| 02/24/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 01/28/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 11/15/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,320.00 | General |
| 07/14/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,320.00 | General |
| 07/08/2021 | Janssen Global Services, LLC | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $810.00 | General |
| Category: Immunology | ||||||
| 03/30/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,160.00 | General |
| 11/12/2020 | Janssen Global Services, LLC | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $540.00 | General |
| Category: Immunology | ||||||
| 10/13/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 06/25/2020 | Janssen Research & Development, LLC | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $3,100.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Rheumatology Pipeline Studies | Novartis Pharma AG | $14,709 | 2 |
About Dr. David Wofsy, MD
Dr. David Wofsy, MD is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619932886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Wofsy, MD has received a total of $150,080 in payments from pharmaceutical and medical device companies, with $26,309 received in 2023. These payments were reported across 69 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($123,907).
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location San Francisco, CA
- Active Since 04/19/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619932886
Products in Payments
- COSENTYX (Biological) $14,709
- NO PRODUCT DISCUSSED (Drug) $9,055
- BENLYSTA (Biological) $8,327
- GAZYVA (Biological) $6,172
- STELARA (Biological) $4,450
- NINLARO (Drug) $1,922
- CENERIMOD $1,620
- Enbrel (Biological) $500.00
- Tremfya (Drug) $25.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Francisco
Dr. Fred Cohen, M.d, M.D
Internal Medicine — Payments: $1.6M
John Teerlink, M.d, M.D
Internal Medicine — Payments: $1.2M
Kenneth Binmoeller, Md, MD
Internal Medicine — Payments: $1.2M
Dr. Hope Rugo, Md, MD
Internal Medicine — Payments: $881,117
Dr. Steven Harris, M.d, M.D
Internal Medicine — Payments: $806,637
Dr. Kenneth Colley, Md, MD
Internal Medicine — Payments: $732,736